SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Matthew Walsh, Executive Vice President & Chief Financial Officer, will present at the Raymond James 38th Annual Institutional Investors Conference at 7:30 a.m. EST on Tuesday, March 7, 2017 in Orlando, FL.
A live webcast of the presentation will be accessible through the Company’s website at http://investor.catalent.com and will be available for replay following the event.
About Catalent, Inc.
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 10,000 people, including over 1,400 scientists, at more than 30 facilities across 5 continents and in fiscal 2016 generated $1.85 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information visit www.catalent.com.
More products. Better treatments. Reliably supplied.™